Saniona AB

{
  "main_header": {
    "sid": 1142984,
    "name": "Saniona AB",
    "stock_name": "Saniona AB",
    "full_name": "Saniona AB",
    "name_url": "stocks-analysis/saniona-ab",
    "exchange": 1,
    "exchangecode": "OME",
    "country_id": 29,
    "currency": "SEK",
    "cmp": "24.30",
    "chg": 15.18,
    "chgp": "166.45%",
    "dir": 1,
    "prev_price": "9.12",
    "mcapval": "3,174.69",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "OMX Stockholm 30",
    "isin": "SE0005794617",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "2.12 M",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/saniona-ab-1142984-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Strong Financial Performance Positions Saniona AB as a Promising Investment Opportunity",
        "link": "https://www.marketsmojo.com/news/mojo-premium/saniona-ab-enters-mojo-stocks-strategy-with-strong-financial-performance-3749271",
        "imagepath": "",
        "date": "2025-12-05 15:38:59",
        "description": "<p><strong>Saniona AB</strong>, a small-cap company, has demonstrated impressive financial results for the quarter ending March 2025, showcasing a robust operational performance that may attract investor interest.</p>\n\n<p>The company reported an operating cash flow of SEK 236.92 MM, marking its highest level to date. This positive cash flow is indicative of the company's ability to generate liquidity from its operations, which is crucial for sustaining growth and funding future initiatives.</p>\n\n<p>In terms of revenue, <strong>Saniona AB</strong> achieved net sales of SEK 323.18 MM for the half-year period, reflecting a significant increase compared to previous periods. This growth in sales is complemented by a net profit of SEK 266.08 MM, further solidifying the company's financial health.</p>\n\n<p>Additionally, the return on capital employed (ROCE) reached an impressive 160.68%, highlighting the effectiven..."
      },
      {
        "title": "Saniona AB Reports Strong Financial Metrics and Significant Yearly Return Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/saniona-abs-stock-rating-downgraded-to-hold-amid-valuation-changes-3697961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanionaAB_mojoScore_3697961.png",
        "date": "2025-11-13 15:26:43",
        "description": "Saniona AB, a small-cap pharmaceutical company, has recently revised its evaluation, reflecting significant changes in financial metrics. The company reported strong quarterly results, with impressive operating cash flow and net sales, alongside favorable valuation ratios and performance indicators, showcasing its robust market presence."
      }
    ],
    "total": 3,
    "sid": "1142984",
    "stock_news_url": "https://www.marketsmojo.com/news/saniona-ab-1142984"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Strong Financial Performance Positions Saniona AB as a Promising Investment Opportunity

2025-12-05 15:38:59

Saniona AB, a small-cap company, has demonstrated impressive financial results for the quarter ending March 2025, showcasing a robust operational performance that may attract investor interest.

The company reported an operating cash flow of SEK 236.92 MM, marking its highest level to date. This positive cash flow is indicative of the company's ability to generate liquidity from its operations, which is crucial for sustaining growth and funding future initiatives.

In terms of revenue, Saniona AB achieved net sales of SEK 323.18 MM for the half-year period, reflecting a significant increase compared to previous periods. This growth in sales is complemented by a net profit of SEK 266.08 MM, further solidifying the company's financial health.

Additionally, the return on capital employed (ROCE) reached an impressive 160.68%, highlighting the effectiven...

Read full news article

Saniona AB Reports Strong Financial Metrics and Significant Yearly Return Performance

2025-11-13 15:26:43

Saniona AB, a small-cap pharmaceutical company, has recently revised its evaluation, reflecting significant changes in financial metrics. The company reported strong quarterly results, with impressive operating cash flow and net sales, alongside favorable valuation ratios and performance indicators, showcasing its robust market presence.

Read full news article

View All News